Skip to main content

Advertisement

SpringerLink
Log in

Effects of alpha lipoic acid supplementation on serum levels of IL-8 and TNF-α in patient with ESRD undergoing hemodialysis

  • Nephrology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Background

Chronic renal failure is a progressive and irreversible loss of kidney function, and the hemodialysis (HD) is one of the most common modalities in this regard. Oxidative stresses [like interleukin-8 (IL-8) and tumor necrosis factor-alpha (TNF-α)] and inflammation are the main risk factors associated with cardiovascular diseases and other complications in many organs in hemodialysis patients; meanwhile, antioxidants like alpha lipoic acid (ALA) may reduce the oxidative stress markers and the levels of inflammatory cytokines, so can improve of the patient’s quality of life.

Methods

In this randomized clinical trial study, 60 HD patients were randomly categorized in two case and control groups. Case group received a daily capsule of 600 mg of ALA supplementation for 8 weeks, and the control group received placebo capsules daily. The serum level of IL-8 and TNF-α was measured in both groups before and after the intervention.

Results

There were no significant differences in age, gender, duration of dialysis, and causative factor for dialysis between both groups (P > 0.05). The mean of IL-8 and TNF-α after the intervention in case group was 26.20 ± 15.34 and 21.25 ± 9.61, respectively; the difference between both groups was not statistically significant (P > 0.05).

Conclusion

Based on the better feeling and other beneficial effects of ALA were found in our study; we can conclude that it is a beneficial and recommended supplement, especially, for diabetic and dialysis patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Prigent A (2008) Monitoring renal function and limitations of renal function tests. Semin Nucl Med 38(1):32–46

    Article  PubMed  Google Scholar 

  2. Sit D, Basturk T, Yildirim S, Karagoz F, Bozkurt N, Gunes A (2014) Evaluation of the serum cystatin C values in prediction of indications for hemodialysis in patients with chronic renal failure. Int Urol Nephrol 46(1):57–62. doi:10.1007/s11255-013-0481-4

  3. Friedman A, Moe S (2006) Review of the effects of omega-3 supplementation in dialysis patients. Clin J Am Soc Nephrol 1(2):182–192

    Article  CAS  PubMed  Google Scholar 

  4. Stenvinkel P, Alvestrand A (2002) Inflammation in end-stage renal disease: sources, consequences, and therapy. Semin Dial 15(5):329–337

    Article  PubMed  Google Scholar 

  5. Lam CWK Inflamation, cytokines and chemokines in chronic kidney disease. eJIFCC 200920/01:11-19. URL: http://www.ifcc.org

  6. Raj DS, Shah H, Shah VO, Ferrando A, Bankhurst A, Wolfe R et al (2003) Markers of inflammation, proteolysis, and apoptosis in ESRD. Am J Kidney Dis 42(6):1212–1220

    Article  CAS  PubMed  Google Scholar 

  7. Ceballos-Picot I, Witko-Sarsat V, Merad-Boudia M, Nguyen AT, Thevenin M, Jaudon MC et al (1996) Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure. Free Radic Biol Med 21(6):845–853

    Article  CAS  PubMed  Google Scholar 

  8. Diplock AT (1994) Antioxidants and disease prevention. Mol Asp Med 15(4):293–376

    Article  CAS  Google Scholar 

  9. Konrad D, Somwar R, Sweeney G, Yaworsky K, Hayashi M, Ramlal T et al (2001) The antihyperglycemic drug alpha-lipoic acid stimulates glucose uptake via both GLUT4 translocation and GLUT4 activation: potential role of p38 mitogen-activated protein kinase in GLUT4 activation. Diabetes 50(6):1464–1471

    Article  CAS  PubMed  Google Scholar 

  10. Olszewska M (2004) The effect of hemodialysis on some parameters of the antioxidant system in the blood of patients with chronic renal failure. Ann Acad Med Stetin 50(1):41–52

    PubMed  Google Scholar 

  11. Biolo G, Stulle M, Bianco F, Mengozzi G, Barazzoni R, Vasile A et al (2008) Insulin action on glucose and protein metabolism during L-carnitine supplementation in maintenance haemodialysis patients. Nephrol Dial Transpl 23(3):991–997

    Article  CAS  Google Scholar 

  12. Rasic-Milutinovic Z, Perunicic G, Pljesa S, Gluvic Z, Ilic M, Stokic E (2007) Metabolic syndrome in HD patients: association with body composition, nutritional status, inflammation and serum iron. Intern Med 46(13):945–951

    Article  PubMed  Google Scholar 

  13. Apostolakis S, Vogiatzi K, Amanatidou V, Spandidos DA (2009) Interleukin 8 and cardiovascular disease. Cardiovasc Res 84(3):353–360

    Article  CAS  PubMed  Google Scholar 

  14. Evans JL, Goldfine ID (2000) Alpha-lipoic acid: a multifunctional antioxidant that improves insulin sensitivity in patients with type 2 diabetes. Diabetes Technol Ther 2(3):401–413

    Article  CAS  PubMed  Google Scholar 

  15. Wollin SD, Jones PJ (2003) Alpha-lipoic acid and cardiovascular disease. J Nutr 133(11):3327–3330

    CAS  PubMed  Google Scholar 

  16. Ghibu S, Richard C, Delemasure S, Vergely C, Mogosan C, Muresan A (2008) An endogenous dithiol with antioxidant properties: alpha-lipoic acid, potential uses in cardiovascular diseases. Ann Cardiol Angeiol (Paris) 57(3):161–165

    Article  CAS  Google Scholar 

  17. Zachwieja J, Zaniew M, Bobkowski W, Stefaniak E, Warzywoda A, Ostalska-Nowicka D et al (2005) Beneficial in vitro effect of N-acetyl-cysteine on oxidative stress and apoptosis. Pediatr Nephrol 20(6):725–731

    Article  PubMed  Google Scholar 

  18. Tuzcu A, Bahceci M, Yilmaz E, Bahceci S, Tuzcu S (2004) The comparison of insulin sensitivity in non-diabetic hemodialysis patients treated with and without recombinant human erythropoietin. Horm Metab Res 36(10):716–720

    Article  CAS  PubMed  Google Scholar 

  19. Khabbazi T, Mahdavi R, Safa J, Pour-Abdollahi P (2012) Effects of alpha-lipoic acid supplementation on inflammation, oxidative stress, and serum lipid profile levels in patients with end-stage renal disease on hemodialysis. J Ren Nutr 22(2):244–250

    Article  CAS  PubMed  Google Scholar 

  20. Pakpour AH, Nourozi S, Molsted S, Harrison AP, Nourozi K, Fridlund B (2011) Validity and reliability of short form-12 questionnaire in Iranian hemodialysis patients. Iran J Kidney Dis 5(3):175–181

    PubMed  Google Scholar 

  21. Ziegler D, Hanefeld M, Ruhnau KJ, Hasche H, Lobisch M, Schutte K et al (1999) Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-lipoic acid in diabetic neuropathy. Diabetes Care 22(8):1296–1301

    Article  CAS  PubMed  Google Scholar 

  22. Ametov AS, Barinov A, Dyck PJ, Hermann R, Kozlova N, Litchy WJ et al (2003) The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. Diabetes Care 26(3):770–776

    Article  CAS  PubMed  Google Scholar 

  23. Chang JW, Lee EK, Kim TH, Min WK, Chun S, Lee KU et al (2007) Effects of alpha-lipoic acid on the plasma levels of asymmetric dimethylarginine in diabetic end-stage renal disease patients on hemodialysis: a pilot study. Am J Nephrol 27(1):70–74

    Article  CAS  PubMed  Google Scholar 

  24. Ziegler D, Schatz H, Conrad F, Gries FA, Ulrich H, Reichel G (1997) Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie. Diabetes Care 20(3):369–373

    Article  CAS  PubMed  Google Scholar 

  25. Jain SK, Lim G (2000) Lipoic acid decreases lipid peroxidation and protein glycosylation and increases (Na(+) + K(+))- and Ca(++)-ATPase activities in high glucose-treated human erythrocytes. Free Radic Biol Med 29(11):1122–1128

    Article  CAS  PubMed  Google Scholar 

  26. Kishi Y, Schmelzer JD, Yao JK, Zollman PJ, Nickander KK, Tritschler HJ et al (1999) Alpha-lipoic acid: effect on glucose uptake, sorbitol pathway, and energy metabolism in experimental diabetic neuropathy. Diabetes 48(10):2045–2051

    Article  CAS  PubMed  Google Scholar 

  27. Stevens MJ, Obrosova I, Cao X, Van HC, Greene DA (2000) Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes 49(6):1006–1015

    Article  CAS  PubMed  Google Scholar 

  28. van Dam PS, van Asbeck BS, Van Oirschot JF, Biessels GJ, Hamers FP, Marx JJ (2001) Glutathione and alpha-lipoate in diabetic rats: nerve function, blood flow and oxidative state. Eur J Clin Invest 31(5):417–424

    Article  PubMed  Google Scholar 

  29. Ramos LF, Kane J, McMonagle E, Le P, Wu P, Shintani A et al (2011) Effects of combination tocopherols and alpha lipoic acid therapy on oxidative stress and inflammatory biomarkers in chronic kidney disease. J Ren Nutr 21(3):211–218

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  30. Panichi V, Taccola D, Rizza GM, Consani C, Ghiadoni L, Filippi C et al (2006) Interleukin-8 is a powerful prognostic predictor of all-cause and cardiovascular mortality in dialytic patients. Nephron Clin Pract 102(2):c51–c58

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Chronic Kidney Diseases Research Center, Tabriz University of Medical Science, Tabriz, Iran

    Javid Safa & Mohammad Reza Ardalan

  2. Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Eastern Azerbaijan, Iran

    Mohammadamin Rezazadehsaatlou

  3. Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

    Mohammadamin Rezazadehsaatlou

  4. Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

    Mehran Mesgari

  5. Nutritional Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

    Reza Mahdavi

  6. Tabriz University of Medical Sciences, Tabriz, Iran

    Maryam Poorkar Jadid

  7. School of Medicine, Tabriz University of Medical Sciences (TUMS), 5165665811, Tabriz, Iran

    Mohammadamin Rezazadehsaatlou

Authors
  1. Javid Safa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mohammad Reza Ardalan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mohammadamin Rezazadehsaatlou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mehran Mesgari
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Reza Mahdavi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Maryam Poorkar Jadid
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mohammadamin Rezazadehsaatlou.

Additional information

This study is registered at IRCT site with this Tracking Number (IRCT2013051813360N1).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Safa, J., Ardalan, M.R., Rezazadehsaatlou, M. et al. Effects of alpha lipoic acid supplementation on serum levels of IL-8 and TNF-α in patient with ESRD undergoing hemodialysis. Int Urol Nephrol 46, 1633–1638 (2014). https://doi.org/10.1007/s11255-014-0688-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-014-0688-z

Keywords

Search

Navigation